BioTime (Israel) Price Prediction and Hype Density Breakdown

BTX -- Israel Stock  

ILS 558.20  11.50  2.02%

We analyze noise-free headlines and recent hype associated with BioTime which may create opportunities for some arbitrage if properly timed. With BioTime hype-based prediction module you can estimate the value of BioTime from the prospective of BioTime response to recently generated media hype and the effects of current headlines on its competitors. The module also provides analysis of price elasticity to changes in media outlook on BioTime over a specific investment horizon. Check also Trending Equities.
Horizon     30 Days    Login   to change

BioTime After-Hype Price Density Analysis

 Next price density 
      Expected price to next headline 

BioTime Estimiated After-Hype Price Volatility

March 23, 2019
Current Value
After-hype Price
Target Odds
Odds Odds
BioTime is Unknown risk asset. Analysis and calculation of next after-hype price of BioTime is based on 2 months time horizon.

BioTime Next Price Analysis

Daily Expected returnPeriod VolatilityHype elasticityRelated hype elasticityAverage news densityRelated news densityNext Expected Hype
 2.27% 8.16% 4.77%  26.83% 2 Events / Month7 Events / MonthIn a few days
Latest traded priceExpected after-news pricePotential return on next major newsAverage after-hype volatility

BioTime Hype Timeline

BioTime is currently traded for 558.20on Tel Aviv Stock Exchange of Israel. The entity has historical hype elasticity of 4.77 and average elasticity to hype of competition of -26.83. BioTime is anticipated not to react to the next headline with price going to stay at about the same level and average media hype impact volatility of 388.57%. The immediate return on the next news is anticipated to be very small where as daily expected return is currently at 2.27%. The volatility of relative hype elasticity to BioTime is about 69.04%%. The volatility of related hype on BioTime is about 69.04% with expected price after next announcement by competition of 531.37. About 46.0% of the company shares are held by company insiders. The company recorded loss per share of 0.58. BioTime had not issued any dividends in recent years. Assuming 30 trading days horizon, the next anticipated press release will be in a few days.
Check also Trending Equities.

BioTime Related Hype Analysis

Investors are also interested in

Purchased over 500 shares
Active a day ago
Check also Trending Equities. Please also try Portfolio Backtesting module to avoid under-diversification and over-optimization by backtesting your portfolios.